GlobeNewswire: Burrill Media LLC Contains the last 10 of 4 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T14:20:12ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/01/05/695041/10114050/en/Biotech-Industry-Shatters-Key-Fundraising-Records-in-2014.html?f=22&fvtc=4&fvtv=22294Biotech Industry Shatters Key Fundraising Records in 20142015-01-05T16:54:12Z<![CDATA[Ongoing fight over drug pricing overshadows industry in the new year SAN FRANCISCO, Jan. 5, 2015 (GLOBE NEWSWIRE) -- The biotech industry shattered records for venture investment, IPOs, and M &A in 2014 as growing enthusiasm for breakthrough technologies and rising stock prices drove investment. Overall, the global life sciences industry raised a total of $104.2 billion, up from $92.9 billion in 2013.]]>burrill year-end indicies 2014burrill 5-yr financings 2014https://www.globenewswire.com/news-release/2014/12/16/691700/10112547/en/G-Steven-Burrill-Issues-Annual-Predictions-for-the-Biotechnology-Industry.html?f=22&fvtc=4&fvtv=22294G. Steven Burrill Issues Annual Predictions for the Biotechnology Industry2014-12-16T13:34:35Z<![CDATA[Focus to shift from promise to execution in 2015 SAN FRANCISCO, Dec. 16, 2014 (GLOBE NEWSWIRE) -- As the end of 2014 approaches, a year of unprecedented financial activity and dealmaking for the biotechnology industry, biotech visionary G. Steven Burrill issued his annual predictions for the life sciences in the new year. ]]>https://www.globenewswire.com/news-release/2014/07/02/648362/10087978/en/Strong-IPO-Market-for-Life-Sciences-Companies-Defines-First-Half-of-2014.html?f=22&fvtc=4&fvtv=22294Strong IPO Market for Life Sciences Companies Defines First Half of 20142014-07-02T12:50:23Z<![CDATA[Despite slowdown in June, more companies have gone public this year than during all of 2013, Burrill Media says SAN FRANCISCO, CALIF., July 2, 2014 (GLOBE NEWSWIRE) -- Life sciences companies raised $4.7 billion globally in 68 initial public offerings during the first half 2014, exceeding the 66 life sciences IPOs completed in all of 2013. While initial public offerings on U.S. exchanges accounted for 55 of those deals and $3.9 billion of the total capital raised, IPO activity in Europe increased with the $333.5 million raised by U.K. biotech Circassia on the London exchange, the biggest deal of the year.]]>https://www.globenewswire.com/news-release/2014/06/23/646058/10086831/en/BIO-2013-to-BIO-2014-Huge-Amount-of-Capital-Raised-by-Life-Sciences-Industry-in-the-Public-Markets.html?f=22&fvtc=4&fvtv=22294BIO 2013 to BIO 2014: Huge Amount of Capital Raised by Life Sciences Industry in the Public Markets2014-06-23T21:50:00Z<![CDATA[SAN FRANCISCO, June 23, 2014 (GLOBE NEWSWIRE) -- The life sciences industry raised $9.1 billion globally through 123 IPOs in the period between last year's BIO International Convention and this year's upcoming meeting. It is both the largest number of IPOs and the most money raised in any 12-month period in the 40+ history of the biotechnology industry and ample reason to be upbeat as the industry's members gather in San Diego for the 2014 BIO International Convention.]]>